[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ACRV":3,"homepage-market-summary":30,"stock-stats-ACRV":171},{"ticker":4,"date":5,"profile":6,"quote":14},"ACRV","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Acrivon Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1\u002FPKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.","76","Watertown, MA",{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},2.01,2.02,2.12,2,2.05,-0.04,-1.95,315654.557812,1939,2.0448,25.47,1.05,439139.25575932715,3.9,972,{"status":31,"indices":32,"watchlist":74,"sectors":97,"benchmarks":151},"success",[33,41,48,55,61,68],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":53,"is_up":39,"sparkline":60,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":39,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":46,"is_up":39,"sparkline":73,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[75,82,90],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":39,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":88,"sparkline":89,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":88,"sparkline":96,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[98,102,107,112,117,122,127,132,136,141,146],{"name":99,"etf":100,"change":26,"price":101,"is_up":39},"Technology","XLK",197.81,{"name":103,"etf":104,"change":105,"price":106,"is_up":39},"Financials","XLF",0.11,53.46,{"name":108,"etf":109,"change":110,"price":111,"is_up":88},"Healthcare","XLV",-1.32,166.2,{"name":113,"etf":114,"change":115,"price":116,"is_up":88},"Consumer Cycl","XLY",-0.03,108.81,{"name":118,"etf":119,"change":120,"price":121,"is_up":88},"Consumer Staples","XLP",-0.33,80.33,{"name":123,"etf":124,"change":125,"price":126,"is_up":39},"Energy","XLE",1.95,62.7,{"name":128,"etf":129,"change":130,"price":131,"is_up":39},"Industrials","XLI",0.99,168.64,{"name":133,"etf":134,"change":120,"price":135,"is_up":88},"Materials","XLB",48.54,{"name":137,"etf":138,"change":139,"price":140,"is_up":88},"Real Estate","XLRE",-0.56,40.68,{"name":142,"etf":143,"change":144,"price":145,"is_up":39},"Utilities","XLU",0.61,39.68,{"name":147,"etf":148,"change":149,"price":150,"is_up":88},"Comm Services","XLC",-0.93,109.94,[152,157,161,166],{"ticker":153,"name":154,"price":155,"change":156,"is_up":39},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":158,"name":159,"price":160,"change":46,"is_up":39},"QQQ","Invesco QQQ Trust",742.03,{"ticker":162,"name":163,"price":164,"change":165,"is_up":39},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":167,"name":168,"price":169,"change":170,"is_up":39},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"company_name":7,"current_price":15,"data_notice":172,"valuation":173,"dates":177,"share_statistics":180,"valuation_ratios":183,"enterprise_valuation":184,"financial_position":189,"financial_efficiency":194,"taxes":199,"price_statistics":200,"income_statement":207,"balance_sheet":213,"cash_flow":221,"margins":227,"dividends":228,"analyst_forecast":231,"fair_value":233,"splits":235},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":174,"enterprise_value":175,"summary":176},89992060.2,57191060.2,"ACRV has a market cap of $89,992,060.20. Enterprise value is $57,191,060.20.",{"latest_fiscal_period_end":178,"earnings_date":9,"ex_dividend_date":9,"summary":179},"2026-03-31","Most recent reported fiscal period end: 2026-03-31.",{"shares_outstanding":181,"owned_by_insiders":9,"owned_by_institutions":9,"summary":182},42853362,"ACRV has 42,853,362 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":185,"ev_sales":9,"ev_ebitda":186,"ev_ebit":187,"ev_fcf":188},-3,-2.93,-2.87,-2.78,{"current_ratio":190,"debt_equity":191,"debt_ebitda":192,"debt_fcf":192,"summary":193},8.98,-0.82,-0.06,"The company has a current ratio of 8.98.",{"roe":195,"roa":196,"revenue_per_employee":9,"profit_per_employee":197,"employee_count":198,"asset_turnover":9},1241.49,-176.59,-250553,76,{"income_tax":9},{"beta_5y":9,"price_change_52w":201,"ma_50":202,"ma_200":203,"rsi_14":204,"avg_volume_20d":205,"summary":206},11.05,1.92,1.82,50.48,318676,"The stock price has changed by +11.05% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":208,"pretax_income":209,"net_income":209,"ebitda":210,"ebit":208,"eps":211,"summary":212},-19902000,-19042000,-19519000,-0.49,"Income statement data is not available for this symbol.",{"cash_and_equiv":214,"total_debt":215,"net_cash":216,"net_cash_per_share":217,"equity_book_value":218,"book_value_per_share":20,"working_capital":219,"summary":220},34064000,1263000,32801000,0.77,-1533800,88166000,"The company reported $34,064,000.00 in cash and $1,263,000.00 in debt.",{"operating_cash_flow":222,"capital_expenditures":223,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":224,"fcf_per_share":225,"summary":226},-17701000,-14000,-20552000,-0.48,"Free cash flow was $-20,552,000.00.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":229,"summary":230},-22.84,"ACRV has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":232},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":234},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":236},"Stock split history is not available for this symbol."]